An industry perspective on the Erice declaration and risk minimisation plans.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Works matching IS 01145916 AND DT 2006 AND VI 29 AND IP 8
Results: 10
1
2
Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions.
- Published in:
- 2006
- By:
- Publication type:
- journal article
3
Drug-induced thrombocytopenia: a population study.
- Published in:
- 2006
- By:
- Publication type:
- journal article
4
Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial.
- Published in:
- 2006
- By:
- Publication type:
- journal article
5
Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?
- Published in:
- 2006
- By:
- Publication type:
- journal article
6
Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England.
- Published in:
- 2006
- By:
- Publication type:
- journal article
7
Safety of Etanercept in Psoriasis: A Critical Review.
- Published in:
- Drug Safety, 2006, v. 29, n. 8, p. 675, doi. 10.2165/00002018-200629080-00004
- By:
- Publication type:
- Article
8
Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines.
- Published in:
- 2006
- By:
- Publication type:
- journal article
9
Long-acting beta2-agonists in asthma: not so SMART?
- Published in:
- 2006
- By:
- Publication type:
- journal article
10
Case reports and drug safety.
- Published in:
- 2006
- By:
- Publication type:
- Editorial